Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Jun '24
Mar '24
Dec '23
Sep '23
Jun '23
Total Qtr Revenue cr
1,410.70
1,110.30
795.60
1,060.80
1,160.20
Other Income Qtr Cr48.1042.0037.0029.4019.70
Operating Revenues Qtr1,362.601,068.30758.601,031.401,140.50

*All values are in Cr.

Operating Expenses Qtr
557.80
571.00
490.50
573.40
612.50
Operating Profit Qtr
804.80
497.30
268.10
458.00
528.00
EBIDT Qtr Cr
852.90
539.30
305.10
487.40
547.70
Depreciation Qtr
44.10
55.50
44.20
43.60
43.50
Net Profit Qtr
668.50
386.30
212.70
369.00
420.30
Basic EPS Qtr
37.32
21.56
11.88
20.60
23.26
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -